Habib Bouzina (Former)
1 – 15 of 15
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Article
- 2021
-
Mark
Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in risk status in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2020
-
Mark
Prolargin and matrix metalloproteinase-2 in heart failure after heart transplantation and their association with haemodynamics
(
- Contribution to journal › Article
-
Mark
Plasma biomarkers in pulmonary arterial hypertension diagnosis, treatment response and risk stratification - utilizing Lund Cardio Pulmonary Register
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics
(
- Contribution to journal › Article
-
Mark
Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
(
- Contribution to journal › Article
-
Mark
Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics
(
- Contribution to journal › Article
-
Mark
Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics
(
- Contribution to journal › Article
- 2019
-
Mark
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
(
- Contribution to journal › Article
- 2018
-
Mark
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2017
-
Mark
Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension
(
- Contribution to journal › Article